• CCK-8: From Metabolic Signal to Translational Insight

  2026-08-26

  Cell Counting Kit-8 (CCK-8) is more than a convenient viability reagent: interpreted through WST-8 chemistry, it can help translational researchers connect cell-state changes with therapeutic mechanism. This article examines how CCK-8 can support exosome-based cartilage repair research while clarifying its limits and the need for orthogonal validation.

• Merimepodib (VX-497): The IMPDH Translation Playbook

  2026-08-25

  Merimepodib (VX-497) offers translational researchers a mechanistically defined way to interrogate IMPDH-dependent guanine nucleotide biosynthesis across antiviral, immunology, and cancer models. Recent PEDV research strengthens the case for treating IMPDH inhibition as a testable host-dependency strategy rather than simply a broad metabolic intervention.

• Heparin Sodium as a Mechanistic Assay Tool

  2026-08-25

  Heparin sodium is more than a glycosaminoglycan anticoagulant: it can serve as a controlled variable in coagulation, nanovesicle uptake, and cell-state studies. This article connects antithrombin-dependent anticoagulation with HSPG-mediated cellular uptake while defining practical controls and experimental limitations.

• Resazurin Cell Viability Assay Kit for Drug Response

  2026-08-24

  Build sensitive, live-cell-compatible drug-response workflows with the Resazurin Cell Viability Assay Kit, from low-density screening to mechanistic apoptosis studies. Its fluorescence and colorimetric formats help separate treatment-driven loss of metabolic activity from assay interference while preserving cells for orthogonal endpoints.

• TMRE mitochondrial membrane potential assay kit Guide

  2026-08-24

  Measure ΔΨm changes across apoptosis, sodium-overload necrosis, and mitochondrial stress models with a workflow built around TMRE fluorescence and CCCP validation. The assay supports both mechanistic cell studies and scalable plate-based mitochondrial function analysis, while careful controls help distinguish depolarization from changes in mitochondrial abundance or cell number.

• Sodium-Driven Mitochondrial Failure in NECSO

  2026-08-23

  Qiao and colleagues show that TRPM4-dependent sodium influx causes necrosis by overwhelming mitochondrial ion handling, suppressing oxidative phosphorylation and the TCA cycle, and depleting cellular ATP. The study provides a mechanistic framework linking sodium overload to mitochondrial energy failure, Na/K-ATPase collapse, cell swelling, and lysis.

• Intermedin, NAMPT/PARP1, and Vascular Senescence

  2026-08-22

  A 2025 mouse study identifies intermedin as a protective regulator of DNA damage and senescent phenotype transition in aortic vascular smooth muscle cells. Its data connect intermedin deficiency and angiotensin II stress with impaired NAMPT/PARP1 signaling, reduced NAD+ availability, and increased vascular-cell senescence.

• Viperin Targets Coronavirus nsp8 to Block Replication

  2026-08-22

  A 2026 study identifies a nonenzymatic antiviral mechanism in which Viperin binds coronavirus nsp8, disrupts replication-transcription complex assembly, and reduces RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus, the work expands the view of Viperin beyond ddhCTP-mediated chain termination and highlights nsp8 as a potentially conserved antiviral target.

• HyperScribe All in One mRNA Synthesis Kit Workflow

  2026-08-21

  Build translation-ready, ARCA-capped and polyadenylated mRNA for vaccine, cell-free translation, antisense, and RNAi studies. This workflow connects kit-level quality control with organ-targeted neoantigen vaccine research while separating validated product specifications from practical optimization steps.

• Caspase-3 Colorimetric Assay Kit Guide

  2026-08-20

  The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a lysate-based, DEVD-dependent colorimetric readout for comparing caspase-3 activity between biological samples and controls. It is suitable for biochemical apoptosis assays and related disease-model studies, but it should not be used alone to prove apoptosis, identify a single protease with absolute specificity, or establish clinical significance.

• Phosphatase Inhibitor Cocktail K1015 Workflow

  2026-08-20

  Phosphatase Inhibitor Cocktail (2 Tubes, 100X), SKU K1015, helps limit endogenous phosphatase activity during sample preparation so phosphorylation-dependent signals are less vulnerable to handling-related loss. It is intended for research workflows such as immunoblotting, immunoprecipitation, kinase assays, and mass spectrometry, but it should not be treated as a universal phosphatase-control reagent or used for diagnostic or medical purposes.

• N1-Methylpseudouridine Preserves mRNA Fidelity

  2026-08-19

  Kim et al. show that N1-methylpseudouridine, the modified nucleoside used in COVID-19 mRNA vaccines, has little effect on ribosomal decoding accuracy or protein-product fidelity. Their integrated translation, RNA duplex, and reverse-transcription assays support the use of this modification in synthetic mRNA workflows while defining important differences from pseudouridine.

• Epacadostat: An IDO1 Assay-to-Immunity Framework

  2026-08-19

  Epacadostat and INCB024360 provide a precise way to investigate IDO1-driven tryptophan metabolism, immune suppression, and T-cell function. This article connects biochemical potency with standardized whole-blood assay design while clarifying the limits of translating immunometabolism findings into immuno-oncology research.

• Heparin sodium as a Nanovesicle Assay Variable

  2026-08-18

  Heparin sodium is more than a glycosaminoglycan anticoagulant: in nanovesicle experiments, it can become an important experimental variable when heparan sulfate proteoglycans mediate cellular uptake. This article translates recent Sertoli-cell findings into practical assay controls, endpoint selection, and research-use considerations for A5066.

• Amitriptyline HCl in BBB Permeability Workflows

  2026-08-18

  Amitriptyline HCl can serve as a mechanistically informative challenge compound for linking receptor pharmacology with blood-brain barrier transport. This workflow combines bidirectional LLC-PK1-MOCK/MDR1 assays, recovery analysis, and lysosomal-trapping controls to distinguish exposure from apparent permeability.

8430 records 1/562 page Next 12345 下5页 Last page